โ† All deals

HAWKHILL THERAPEUTICS Ltd

BiotechnologyBiotechnologyObesity TherapyUniversity Spinout
๐Ÿ“ Dundee, Scotland, United Kingdomโ€ข Founded 2025โ€ข 2-10 employees
StreetZero Signal 69
Be the first to signal interest

About HAWKHILL THERAPEUTICS Ltd

Hawkhill Therapeutics Ltd is a biotechnology company based in Dundee, Scotland, focused on developing first-in-class oral therapies for obesity that selectively reduce fat while preserving muscle mass. The company was founded in 2025 and emerged from the innovation ecosystem at the University of Dundee. It operates with a team of 2-10 employees and is located at the Life Sciences Innovation Hub in Dundee.

LATEST FUNDINGPrivate Placement
$291K
Announced 2026-09-29
TOTAL RAISED$290,530
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for HAWKHILL THERAPEUTICS Ltd.

Free plan includes 3 full deal profiles every month.

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • Founded in 2025 as a University of Dundee spinout in biotechnology.
  • Developing first-in-class oral obesity therapy that preserves muscle mass.
  • Raised $290,530 via private placement with undisclosed investors.
  • Operates from Life Sciences Innovation Hub in Dundee with 2-10 employees.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account